A slight correlation between Aβ42 and hypocretin-1 levels was recently reported in 6 patients with AD and 6 healthy controls, with no between-group difference in CSF hypocretin-1 levels and its circadian amplitude (Slats et al., 2012). This evidence concerns the gene HCRT and Alzheimer disease.